Last reviewed · How we verify

Taurolidine heparin — Competitive Intelligence Brief

Taurolidine heparin (Taurolidine heparin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antimicrobial/anticoagulant combination. Area: Infectious Disease / Vascular Access Management.

marketed Antimicrobial/anticoagulant combination Infectious Disease / Vascular Access Management Small molecule Live · refreshed every 30 min

Target snapshot

Taurolidine heparin (Taurolidine heparin) — Ain Shams University. Taurolidine heparin is a combination antimicrobial and anticoagulant agent that prevents bacterial biofilm formation and thrombosis in vascular access devices.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Taurolidine heparin TARGET Taurolidine heparin Ain Shams University marketed Antimicrobial/anticoagulant combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antimicrobial/anticoagulant combination class)

  1. Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Taurolidine heparin — Competitive Intelligence Brief. https://druglandscape.com/ci/taurolidine-heparin. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: